Right side Colon cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged 18-78 years old; 2. Colorectal adenocarcinoma confirmed by colonoscopy and pathological biopsy; 3. Abdominal CT showed that the distal and proximal primary lesions were located in ileocecum and ascending colon; 4. The T stage of the tumor was less than or equal to 3 according to the imaging diagnosis at the time of initial treatment; 5. No abdominal metastasis was diagnosed by imaging at the time of initial treatment; 6. American Society of Anesthesiologists (ASA) score I-III; 7. Patients were able to understand the study protocol and willing to participate in the study, and provided written informed consent;
Exclusion criteria
Exclusion criteria: 1. Preoperative examination suggested synchronous multiple primary colorectal cancer or combined with other diseases requiring intestinal segment resection; 2. Preoperative imaging examination or intraoperative exploration indicated: 1) serosal or adjacent organ invasion (cT4) involving surrounding organs, 2) distant metastasis; 3) unable to perform R0 resection; 3. Previous history of colorectal cancer; 4. Patients who received preoperative neoadjuvant therapy; 5. History of other malignant tumors or familial adenomatous polyposis diagnosed within the past 5 years, except cured cervical carcinoma in situ, basal cell carcinoma, thyroid papillary carcinoma or skin squamous cell carcinoma; 6. Not suitable or intolerant to laparoscopic surgery; 7. Emergency surgery is needed when complicated with intestinal obstruction, intestinal perforation, intestinal bleeding, etc. 8. Patients with severe liver and kidney function, cardiopulmonary function, coagulation dysfunction or combined with serious underlying diseases can not tolerate surgery; 9. A history of severe mental illness; 10. Pregnant or lactating women; 11.MDT to discuss patients deemed ineligible for the study; 12. The patient could not understand the conditions and objectives of the study and refused to sign an informed colleague's letter;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 3-year disease-free survival rate (DFS); | — |
Secondary
| Measure | Time frame |
|---|---|
| 30-day perioperative complications;5-year overall survival rate (OS); | — |
Countries
China
Contacts
Zhejiang Cancer Hospital